Tag: cannabinoid pharmaceutical R&D
AusCann raises A$33.4m via share placement
ASX-listed medical marijuana company AusCann has successfully raised A$33.4 million via a share placement to institutional and sophisticated investors from North America and Australia, including...
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
